性别肯定阴道成形术后膀胱过度活动症症状变化
这项回顾性纵向研究评估了53名跨性别女性在阴道成形术前后膀胱过度活动症(OAB)症状的变化,使用OAB-q SF问卷。
要点
- 年龄最大四分位组(44-71岁)症状困扰和HRQL恶化最明显。
核心结论
- 阴道成形术患者可能出现OAB症状加重并影响生活质量,在年龄较大者和PFV者中更明显,但症状变化的临床意义不明确,总体影响有限。
研究设计与样本
- 回顾性纵向研究,纳入53名接受阴道成形术的跨性别女性,术前术后完成OAB-q SF问卷,中位术后问卷时间29周。
临床怎么用
- 术后应关注OAB症状,尤其对年龄较大和接受PFV的患者。
局限性
- 症状变化的临床意义不明确,总体影响有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess overactive bladder symptoms and identify risk factors for worsened symptoms after vaginoplasty in transgender women. METHODS: This was a retrospective longitudinal study examining changes in overactive bladder (OAB) symptoms of transgender women undergoing vaginoplasty. All participants completed the 19-question Overactive Bladder Questionnaire Short-Form (OAB-q SF) to assess urinary symptoms before and after vaginoplasty. Medians of OAB-q SF scores, including Symptom Bother and Health-Related Quality of Life (HRQL) sub-scores, were measured. Changes in scores were compared using Wilcoxon signed-rank tests. Data were further stratified by factors such as age at the time of surgery and type of vaginoplasty performed. RESULTS: Fifty-three transgender women undergoing vaginoplasty were evaluated. Median time from surgery to postoperative questionnaire was 29 weeks. About 53% underwent peritoneal flap vaginoplasty (PFV), 21% penile inversion vaginoplasty (PIV), 15% minimal depth vaginoplasty (MDV), and 11% sigmoid vaginoplasty (SV). For all patients, statistically significant HRQL declines were noted postoperatively (96.9/100 vs 93.8/100, P = .020). When stratified by age, the oldest quartile of patients (44 to 71 years old) experienced the largest worsening of Symptom Bother (6.7/100 vs 20/100, P = .020) and HRQL (96.9/100 vs 90.8/100, P = .008). When stratified by vaginoplasty type, PFV had a significant decrease in HRQL (96.9/100 vs 93.8/100, P = .023). CONCLUSION: Patients undergoing vaginoplasty can experience worsening of overactive bladder symptoms affecting their quality of life, which in our series was more pronounced in older individuals and those undergoing PFV. However, the clinical significance of these symptom changes is unclear, suggesting that overall effects of vaginoplasty on OAB symptoms are limited.
引用
- Ho P, Torres C, Andrade F, et al. Overactive Bladder After Gender-affirming Vaginoplasty. Urology. 2026. PMID: 41655856. doi:10.1016/j.urology.2026.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。